Intergroup statement - opportunistic salpingectomy - molecular pathology, clinical outcomes and implications for practice

Sep 23, 2026

Uploaded by Jacob

Opportunistic salpingectomy removes both fallopian tubes as part of a surgery planned for other reasons, aiming at primary prevention of ovarian cancer. The statement contrasts this approach with high-risk patients carrying germline mutations such as BRCA1/2, for whom risk-reducing salpingo-oophorectomy is generally recommended. It summarizes evidence that serous intraepithelial carcinomas (STIC) and early genetic changes are detected in fimbrial funnel specimens, reshaping views of high-grade serous cancer pathogenesis. It reviews molecular pathology findings, clinical implications, and reported patient outcomes, weighing potential benefits against surgical morbidity.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages9

Reading Time23 min

AccessFree to download

Opportunistic salpingectomy—a strategy for cancer prevention?

Prevention rationale and epidemiology

Tumor classification and BRCA-associated risk

Screening and early detection challenges

STIC identification and prevention hypothesis

Adoption of guidelines and recommendations

Frequency of precursor lesions

Archives of Gynecology and Obstetrics (2025) 311:1451–1459 [https://doi.org/10.1007/s00404-025-07974-z](https://doi.org/10.1007/s00404-025-07974-z) Intergroup statement: opportunistic salpingectomy—molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North‑Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss) Martin Pölcher1 · Pauline Wimberger2 · Ivo Meinhold‑Heerlein3 · Ingo Runnebaum4 · Susanne Schüler‑Toprak5 · Sven Mahner6 · Christoph Grimm7 · Viola Heinzelmann‑Schwarz8,11 · Annette Hasenburg9 · Jalid Sehouli10 Received: 25 January 2025 / Accepted: 29 January 2025 / Published online: 2 April 2025 © The Author(s) 2025 Abstract Opportunistic salpingectomy is defined as the removal of both fallopian tubes as part of a surgical procedure planned for other reasons. The goal is primary prevention of ovarian cancer. The procedure is offered to patients who are not known to be at increased risk of developing ovarian cancer. This is in contrast to high-risk patients with a germline mutation, particularly BRCA1/2, for whom risk-reducing salpingo-oophorectomy is generally recommended. Premalignant cells and early occult cancers have been detected in RRSO specimens in the fimbrial funnel region, but not on the ovarian surface. The presence of mitoses, nuclear atypia, and staining in response to p53 mutation in these serous intraepithelial carcinomas (STIC) indicates the initial genetic changes in the fallopian tube mucosa that subsequently lead to the development of advanced peritoneal carcinomas. The identification of STICs has challenged the traditional view of the pathogenesis of the largest subset of epithelial ovarian cancers, namely the high-grade serous cancers of the ovary, fallopian tubes, and peritoneum. Ina position statement published in 2015, the German Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Kommission Ovar recommended that patients be informed of the latest findings on the development and potential benefits of bilateral salpingectomy at the time of hysterectomy. This may reduce the risk of developing ovarian cancer later in life. However, the scientific evidence has not been deemed sufficient to justify a general recommendation. In the same year, the Austrian AGO published a statement recommending the broad use of opportunistic salpingectomy without reservation. This review examines the current status of molecular pathology studies, recent evidence on the clinical implications of STIC, new data on the use of opportunistic salpingectomy, and published patient outcomes since then. The question of whether the potential benefit of opportunistic salpingectomy, outweighs the potential harms associated with surgical morbidity, which have not been conclusively excluded, should be revisited in light of these recent data. Keywords Prevention · Ovarian cancer · Opportunistic salpingectomy · STIC Opportunistic salpingectomy—a strategy for cancer prevention? Worldwide, an estimated 324,000 new cases of ovarian cancer are diagnosed each year, resulting in approximately 207,000 deaths from the disease. This means that ovarian cancer has the highest mortality rate of all gynecological cancers [1] . Malignant ovarian tumors can be classified according to their origin as germ cell tumors, germinal-strand stromal tumors, or surface epithelial ovarian Extended author information available on the last page of the article carcinomas. The latter are further subdivided into five distinct morphologic subtypes: Brenner, mucinous, clear cell, endometrioid, and serous. Serous carcinomas can be further subdivided into low-grade and high-grade serous tubal and ovarian carcinoma (HGSTOC) . The largest group of malignant ovarian tumors, accounting for 70–80% of all carcinomas, are HGSTOC, which also correlate with the worst prognosis. Individuals with a BRCA1/2 mutation, who are at high risk of developing ovarian cancer, typically pr

FAQs

What is opportunistic salpingectomy and what is its prevention goal?

Opportunistic salpingectomy removes both fallopian tubes during a surgery planned for other reasons. Its goal is primary prevention of ovarian cancer.

How does opportunistic salpingectomy differ from recommendations for BRCA1/2 high-risk patients?

High-risk patients with germline mutations, particularly BRCA1/2, are generally recommended to undergo risk-reducing salpingo-oophorectomy. Opportunistic salpingectomy is offered to patients not known to be at increased risk.

What is the significance of STIC in the proposed prevention strategy?

STICs and early occult malignancy findings in fimbrial funnel regions support that early genetic changes can originate in the fallopian tube mucosa. This challenges the traditional pathogenesis model for many high-grade serous cancers.

Sep 23, 2026

Uploaded by Jacob